09:20 AM EDT, 03/30/2026 (MT Newswires) -- Health care stocks were advancing pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) 0.4% higher and the iShares Biotechnology ETF (IBB) up 1%.

United Therapeutics ( UTHR ) shares were up more than 18% after the company said a pivotal study of nebulized Tyvaso in idiopathic pulmonary fibrosis met the primary efficacy endpoint, increasing forced vital capacity by 130.1 mL at 52 weeks and reducing the risk of clinical worsening compared with placebo.

Takeda Pharmaceutical ( TAK ) stock was up more than 2% after the company said about 70% of patients treated with zasocitinib displayed clear or almost clear skin by the end of 16 weeks in its phase 3 plaque psoriasis studies.

Novartis ( NVS ) shares were up more than 1% after the company said its drug Fabhalta showed "statistically significant, clinically meaningful improvement" in kidney function among patients with IgA nephropathy, or Berger's disease, in a phase three study.